Immucell (ICCC) Gains from Sales and Divestitures (2010 - 2025)
Immucell (ICCC) posted Gains from Sales and Divestitures of -$46,294 for Q4 2025, compared with -$834.00 a year earlier.
Powered by 
Analysis
Immucell (ICCC) Gains from Sales and Divestitures (2010 - 2025) Analysis & Trends
For FY2025, Immucell's Gains from Sales and Divestitures came in at -$106,350.
- In prior years, Immucell's Gains from Sales and Divestitures was -$15,391 in FY2024, -$8,099 in FY2023, $7,334 in FY2022 and -$30,963 in FY2021.
- Quarterly Gains from Sales and Divestitures has run from a low of -$62,319 in Q3 2025 to a high of $11,000 in Q1 2022 over five years.
- According to Business Quant data, Gains from Sales and Divestitures for the three prior quarters was -$62,319 (Q3 2025), $7,128 (Q2 2025) and -$4,865 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Immucell | 93.09 Mn | 70.54 Mn | 2.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -46,294.00 |
| Sep 30, 2025 | -62,319.00 |
| Jun 30, 2025 | 7,128.00 |
| Mar 31, 2025 | -4,865.00 |
| Dec 31, 2024 | -834.00 |
| Sep 30, 2023 | 68.00 |
| Jun 30, 2023 | 77.00 |
| Mar 31, 2023 | -8,243.00 |
| Dec 31, 2022 | -3,666.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 1,315.00 |
| Sep 30, 2021 | -42,278.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | -36,037.00 |
| Mar 31, 2020 | -3,266.00 |
| Dec 31, 2017 | -1,340.00 |
| Mar 31, 2017 | 3,663.00 |
| Dec 31, 2016 | -23,276.00 |
| Sep 30, 2016 | -2,109.00 |
| Sep 30, 2015 | -3,992.00 |
API Access
Immucell Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();